Literature DB >> 7560291

Colocalization of gamma-aminobutyric acid with vasopressin, vasoactive intestinal peptide, and somatostatin in the rat suprachiasmatic nucleus.

R M Buijs1, J Wortel, Y X Hou.   

Abstract

The seemingly contradictory observations in previous publications that gamma-aminobutyric acid (GABA) is detected in all cell bodies of the suprachiasmatic nucleus (SCN) and that terminals originating from the SCN are only 20-30% GABA positive prompted us to investigate whether this might be explained by a preference of colocalization in terminals of certain peptidergic neurons in the SCN or by a day/night rhythm in GABA synthesis. At three different circadian times, animals were perfusion fixed, and their SCNs were stained for vasopressin (VP), somatostatin (SOM), or vasoactive intestinal polypeptide (VIP). Subsequently, the number of GABA peptide-positive terminals was determined using GABA postembedding staining in ultrathin sections. It appeared that the highest percentage of colocalization with GABA was detected in VIP terminals (38%) and the lowest in VP terminals (15%). No differences in colocalization percentages could be observed in any parameter at any circadian time. In the dorsomedial hypothalamus, one of the target areas of the VP and VIP fibers from the SCN, a colocalization of GABA within VP and VIP terminals was found similar to that in the SCN. In the region of the somatostatin-containing neurons in the SCN, a number of axoaxonal contacts could be observed that sometimes exhibited synaptic specializations. In nearly all cases, the axoaxonic terminals contained GABA and/or SOM. The conclusion is that the high level of intrinsic GABAergic connections in the SCN represents a putatively powerful mechanism to synchronize or shut down the activity of the SCN. We discuss the possibility that, depending on the firing frequency of the neurons, the colocalization of GABA with all peptides under investigation allows for the selection of which transmitter is released, the peptidergic one or the amino acid.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560291     DOI: 10.1002/cne.903580304

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  17 in total

1.  Neuropeptide-mediated calcium signaling in the suprachiasmatic nucleus network.

Authors:  Robert P Irwin; Charles N Allen
Journal:  Eur J Neurosci       Date:  2010-10-12       Impact factor: 3.386

2.  Electrophysiological and morphological heterogeneity of neurons in slices of rat suprachiasmatic nucleus.

Authors:  C M Pennartz; M T De Jeu; A M Geurtsen; A A Sluiter; M L Hermes
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

Review 3.  The rhythmic GABAergic system.

Authors:  D P Cardinali; D A Golombek
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 4.  Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network.

Authors:  H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2014-08-04       Impact factor: 8.606

5.  Chronic alcohol consumption and withdrawal do not induce cell death in the suprachiasmatic nucleus, but lead to irreversible depression of peptide immunoreactivity and mRNA levels.

Authors:  M D Madeira; J P Andrade; A R Lieberman; N Sousa; O F Almeida; M M Paula-Barbosa
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Morphological heterogeneity of the GABAergic network in the suprachiasmatic nucleus, the brain's circadian pacemaker.

Authors:  M Castel; J F Morris
Journal:  J Anat       Date:  2000-01       Impact factor: 2.610

7.  Colocalization of neurotransmitters in presynaptic boutons of inhibitory synapses in the lamprey spinal cord.

Authors:  N P Veselkin; V O Adanina; J P Rio; J Repérant
Journal:  Neurosci Behav Physiol       Date:  2000 Sep-Oct

Review 8.  Vasoactive intestinal peptide and the mammalian circadian system.

Authors:  Andrew M Vosko; Analyne Schroeder; Dawn H Loh; Christopher S Colwell
Journal:  Gen Comp Endocrinol       Date:  2007-05-26       Impact factor: 2.822

Review 9.  The dynamics of GABA signaling: Revelations from the circadian pacemaker in the suprachiasmatic nucleus.

Authors:  H Elliott Albers; James C Walton; Karen L Gamble; John K McNeill; Daniel L Hummer
Journal:  Front Neuroendocrinol       Date:  2016-11-25       Impact factor: 8.606

Review 10.  Network-mediated encoding of circadian time: the suprachiasmatic nucleus (SCN) from genes to neurons to circuits, and back.

Authors:  Marco Brancaccio; Ryosuke Enoki; Cristina N Mazuski; Jeff Jones; Jennifer A Evans; Abdelhalim Azzi
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.